Jozef Madzo to Oncogene Proteins, Fusion
This is a "connection" page, showing publications Jozef Madzo has written about Oncogene Proteins, Fusion.
Connection Strength
0.693
-
Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study. Cancer. 2003 Jan 01; 97(1):105-13.
Score: 0.210
-
ETV6/RUNX1 (TEL/AML1) is a frequent prenatal first hit in childhood leukemia. Blood. 2011 Jan 06; 117(1):368-9; author reply 370-1.
Score: 0.092
-
Revealing the role of TEL/AML1 for leukemic cell survival by RNAi-mediated silencing. Leukemia. 2011 Feb; 25(2):313-20.
Score: 0.091
-
Prenatal origin of childhood AML occurs less frequently than in childhood ALL. BMC Cancer. 2006 Apr 21; 6:100.
Score: 0.066
-
TEL/AML 1 real-time quantitative reverse transcriptase PCR can complement minimal residual disease assessment in childhood ALL. Leukemia. 2005 Jul; 19(7):1296-7.
Score: 0.063
-
TEL/AML1 and immunoreceptor gene rearrangements-which comes first? Leuk Res. 2005 Jun; 29(6):633-9.
Score: 0.061
-
Upregulation of asparagine synthetase fails to avert cell cycle arrest induced by L-asparaginase in TEL/AML1-positive leukaemic cells. Leukemia. 2004 Mar; 18(3):434-41.
Score: 0.057
-
ABL1 kinase as a tumor suppressor in AML1-ETO and NUP98-PMX1 leukemias. Blood Cancer J. 2023 03 23; 13(1):42.
Score: 0.053